2020 annual financial data
Intellia Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -86.06%.
Operating income was -136,583,000 USD and net income was -125,568,000 USD.
Operating cash flow was -49,912,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,994,000 USD
- Operating income
- -136,583,000 USD
- Net income
- -125,568,000 USD
- Operating cash flow
- -49,912,000 USD